Defibrillator Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Report Covers Implantable Cardioverter Defibrillator Market Insights and it is segmented by Product (Implantable Cardioverter Defibrillator (ICD) and External Defibrillator (ED)), End User (Hospitals, Emergency Care, Home Care, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Market values are Provided (in USD million) for the above segments.

Defibrillator Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Defibrillator Market Size

Defibrillator Market Summary
Study Period 2021 - 2030
Market Size (2025) USD 14.61 Billion
Market Size (2030) USD 20.69 Billion
CAGR (2025 - 2030) 7.20 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Defibrillator Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Defibrillator Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Defibrillator Market Analysis

The Defibrillator Market size is estimated at USD 14.61 billion in 2025, and is expected to reach USD 20.69 billion by 2030, at a CAGR of 7.2% during the forecast period (2025-2030).

The COVID-19 epidemic has altered several facets of the healthcare system, including how people are treated for cardiac arrests both outside and within hospitals. There was a reduction in cardiac procedures during the pandemic period due to the strict regulation by various governments across the world. For instance, the EHRA article published in March 2021 mentioned that during the pandemic period, cardiac resynchronization therapy procedures with defibrillation devices decreased by 45%, and procedures involving implantable cardioverter defibrillators were 45% in England. Such reductions in the cardiovascular procedures involving defibrillator devices during the pandemic period had a notable impact on the growth of the market. However, the resumption of all cardiac surgical procedures after the relaxation of strict regulations during the post-pandemic period is expected to contribute to the growth of the market over the forecast period.

The increasing prevalence of cardiovascular diseases and technological advancements in the field of defibrillators are the major drivers for the market. For instance, the British Heart Foundation (BHF) data published in January 2022 reported that the most common heart conditions affected globally were coronary (ischemic) heart disease (global prevalence estimated at 200 million), peripheral arterial (vascular) disease (110 million), stroke (100 million) and atrial fibrillation (60 million). The report also mentioned that the prevalence of heart and circulatory diseases in North America was 46 million, in Europe 99 million, in Africa 58 million, in South America 32 million, in Asia and Australia 310 million. Therefore, the high burden of cardiovascular diseases is expected to contribute to the growing demand for defibrillators as they are widely used in reviving patients from sudden cardiac arrest by providing sufficient oxygen and blood to the required organs via a sudden shock, thereby fueling the growth of the market.

Additionally, the increasing product launches by various governments and various market players are also expected to contribute to the growth of the market. For instance, in February 2022, Infrastructure Minister Nichola Mallon unveiled one of the first life-saving defibrillators that will be installed across the public transport network in Northern Ireland. Additionally, in July 2021, Jeevtronics Pvt Ltd developed SanMitra 100 HCT, the hand-cranked dual-powered defibrillator. The device is affordable, low-weight, and considered more reliable than traditional defibrillators by experts as it can be used even in areas where electricity is unavailable.

However, the stringent regulatory framework is likely to hinder market growth over the forecast period.

Defibrillator Industry Overview

The defibrillator market is fragmented in nature due to the presence of several companies operating globally as well as regionally. The competitive landscape includes an analysis of a few international as well as local companies which hold the market shares and are well known including Boston Scientific Corporation, Koninklijke Philips NV, Medtronic PLC, Nihon Kohden Corporation, and Abbott Laboratories among others.

Defibrillator Market Leaders

  1. Boston Scientific Corporation

  2. Abbott Laboratories

  3. Medtronic PLC

  4. Koninklijke Philips NV

  5. Nihon Kohden Corporation

  6. *Disclaimer: Major Players sorted in no particular order
Defibrillator Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Defibrillator Market News

  • In September 2022, Kauvery Hospital launched the Restart Heart Foundation in Chennai India. Through this foundation, over 100 automated external defibrillators were installed at key sites across Chennai, India. 
  •  In August 2022, Medtronic announced that its investigational EV ICD (extravascular implantable cardioverter defibrillator) system met trial endpoints. This device aimed to avoid certain risks of traditional, transvenouss ICDs as iy lead is placed outside the heart and veins, under the sternum using a minimally invasive approach.

Defibrillator Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Defination
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Cardiovascular Diseases
    • 4.2.2 Technological Advancements in the Field of Defibrillators
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Framework
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Product
    • 5.1.1 Implantable Cardioverter Defibrillator (ICD)
    • 5.1.1.1 Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
    • 5.1.1.2 Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
    • 5.1.1.3 CRT with Pacemaker and ICD Function (CRT-D)
    • 5.1.2 External Defibrillator (ED)
    • 5.1.2.1 Automated External Defibrillator (AEDs)
    • 5.1.2.1.1 Semi-automated External Defibrillators
    • 5.1.2.1.2 Fully-automated External Defibrillators
    • 5.1.3 Manual External Defibrillator
    • 5.1.3.1 Wearable Cardioverter Defibrillators (WCDs)
  • 5.2 By End User
    • 5.2.1 Hospitals
    • 5.2.2 Emergency Care
    • 5.2.3 Home Care
    • 5.2.4 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Boston Scientific Corporation
    • 6.1.3 Cardiac Science Corporation
    • 6.1.4 Defibtech LLC
    • 6.1.5 Koninklijke Philips NV
    • 6.1.6 LivaNova PLC
    • 6.1.7 Medtronic PLC
    • 6.1.8 Nihon Kohden Corporation
    • 6.1.9 Physio-Control Inc.
    • 6.1.10 ZOLL Medical Corporation
    • 6.1.11 Bexen Cardio
    • 6.1.12 Mindray Medical International Ltd.
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Defibrillator Industry Segmentation

As per the scope of the report, a defibrillator is a life-saving device that helps deliver a therapeutic shock to a patient's heart in life-threatening conditions, such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. The Defibrillator Market is segmented by Product (Implantable Cardioverter Defibrillator (ICD) (Transvenous Implantable Cardioverter Defibrillator (T-ICDs), Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs), CRT with Pacemaker and ICD Function (CRT-D)) and External Defibrillator (ED) (Automated External Defibrillator (AEDs) (Semi-automated External Defibrillators, Fully-automated External Defibrillators) (Manual External Defibrillator (Wearable Cardioverter Defibrillators (WCDs))), End User (Hospitals, Emergency Care, Home Care, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Product Implantable Cardioverter Defibrillator (ICD) Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
CRT with Pacemaker and ICD Function (CRT-D)
External Defibrillator (ED) Automated External Defibrillator (AEDs) Semi-automated External Defibrillators
Fully-automated External Defibrillators
Manual External Defibrillator Wearable Cardioverter Defibrillators (WCDs)
By End User Hospitals
Emergency Care
Home Care
Other End Users
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Defibrillator Market Research FAQs

How big is the Defibrillator Market?

The Defibrillator Market size is expected to reach USD 14.61 billion in 2025 and grow at a CAGR of 7.20% to reach USD 20.69 billion by 2030.

What is the current Defibrillator Market size?

In 2025, the Defibrillator Market size is expected to reach USD 14.61 billion.

Who are the key players in Defibrillator Market?

Boston Scientific Corporation, Abbott Laboratories, Medtronic PLC, Koninklijke Philips NV and Nihon Kohden Corporation are the major companies operating in the Defibrillator Market.

Which is the fastest growing region in Defibrillator Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Defibrillator Market?

In 2025, the North America accounts for the largest market share in Defibrillator Market.

What years does this Defibrillator Market cover, and what was the market size in 2024?

In 2024, the Defibrillator Market size was estimated at USD 13.56 billion. The report covers the Defibrillator Market historical market size for years: 2021, 2022, 2023 and 2024. The report also forecasts the Defibrillator Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Defibrillator Industry Report

Statistics for the 2025 Defibrillator market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Defibrillator analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Defibrillator Market Report Snapshots